IGF-1 LR3: Extended Half-Life Variant in Research
IGF-1 LR3 is a recombinant analogue of insulin-like growth factor 1, engineered for extended serum half-life. This article reviews the scientific rationale behind its design and the preclinical research exploring its effects on cell proliferation and metabolism.
Background: IGF-1 and Its Significance
Insulin-like Growth Factor 1 (IGF-1) is a peptide hormone structurally similar to insulin that plays a critical role in childhood growth and continues to have anabolic effects in adults. It mediates many of the growth-promoting effects of Growth Hormone (GH).
Native IGF-1 has a relatively short half-life in serum (~10-20 minutes when free) due to rapid binding by IGF-binding proteins (IGFBPs).
What is IGF-1 LR3?
IGF-1 LR3 (Long R3 IGF-1) is a synthetic variant with two key modifications:
- Arginine (R) substituted for glutamic acid at position 3 — reduces IGFBP binding affinity
- 13 amino acid N-terminal extension — further reduces IGFBP binding
These modifications result in an extended half-life of approximately 20-30 hours, making it a valuable tool for in vitro and in vivo research where sustained IGF-1 receptor activation is desired.
Research Applications
Cell Culture (In Vitro)
IGF-1 LR3 is widely used in cell culture as a growth supplement, particularly in:
- Serum-free media formulations
- Bioreactor cell culture for biopharmaceutical production
- Proliferation and survival assays
In Vivo Animal Studies
Preclinical studies have used IGF-1 LR3 to investigate:
- Muscle fiber hypertrophy and satellite cell activation
- Metabolic effects on glucose uptake
- Neuroprotective pathways in CNS injury models
Research Considerations
Because IGF-1 LR3 has reduced IGFBP binding, its pharmacodynamics differ significantly from native IGF-1. Researchers should account for this when designing experiments and interpreting results relative to endogenous IGF-1 biology.
As with all peptide research tools, all in vivo applications are strictly preclinical and not intended for human use.
Conclusion
IGF-1 LR3's engineered pharmacokinetic profile makes it a useful and well-characterized research reagent. Its widespread use in cell culture attests to its stability and biological activity when sourced at high purity.
Research Disclaimer
This article is intended for educational and research purposes only. All products referenced are for laboratory research use only and are not approved for human or animal consumption. PeptidXs does not provide medical advice.
